InterCure earnings missed by $0.07, revenue fell short of estimates

Investing.com – InterCure (NASDAQ: ) reported first quarter EPS of $0.00, $0.07 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $28.99M versus the consensus estimate of $31.87M.

InterCure’s stock price closed at $2.58. It is down -19.12% in the last 3 months and down -64.07% in the last 12 months.

InterCure saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See InterCure’s stock price’s past reactions to earnings here.

According to InvestingPro, InterCure’s Financial Health score is “great performance”.

Check out InterCure’s , and InterCure’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar